As the number of daily coronavirus cases in India continues to fall and our lives begin to resemble what they were before the devastating epidemic began, it may be time to consider how the pandemic has affected us – every one of us.
The pandemic has caused financial and public health issues around the world. The healthcare system in all countries was severely strained, and the economic burden of the epidemic is still being felt by the majority of us.
Earlier this month, the UK stated that Indians who have been completely vaccinated with the Covishield vaccination will no longer be required to undergo quarantine. In the past, India has asked various European nations to adopt Covishield and other vaccines used in India for Indian nationals travelling to Europe.
Earlier this month, the UK declared that Indians who have been properly vaccinated with the Covishield vaccination will no longer be required to undergo quarantine upon arrival in the UK from October 11. The Serum Institute of India manufactures Covishield, an Oxford-AstraZeneca vaccine.
Earlier this month, the UK declared that Indians who have been properly vaccinated with the Covishield vaccination will no longer be required to undergo quarantine upon arrival in the UK from October 11. The Serum Institute of India manufactures Covishield, an Oxford-AstraZeneca vaccine.
As of Friday, October 22, 2021, India is believed to have completed 100 crore vaccines against COVID-19, mostly using Covishield and Bharat Biotech’s Covaxin. Prime Minister Narendra Modi announced the vaccination program on Friday, saying it was a reflection of the country’s strengths and a chapter in the history of a ‘new India.’
Meantime, the vaccine is, however, anticipating World Health Organization permission for an emergency practice, which is in the operations. WHO said a review of India’s Covaxin has begun. During a phone conversation with Health Minister Mansukh Mandaviya on October 19, WHO chief Tedros Adhanom Ghebreyesus discussed, among other things, the emergency use listing of Covaxin.
